STIC Investment
VC Fund
Seoul, South Korea
STIC Investment is a VC fund in Seoul focused on Medical and E-Commerce. STIC Investments is a private equity firm that invests in management buy-outs, acquisitions, restructuring other corporate situations. It is one of the largest and most experienced private equity firms in Korea. STIC seeks to create growth and prosperity in economies across Asia through investing in companies that engage in promising businesses.
- Total investments:
- 46
- Last investment:
- Lead investor:
- 52%
- Fund size:
- $1.6B
- Last fund:
Last updated:
For AI agents: llms.txt
Industries STIC Investment invests in
Stages STIC Investment invests in
Countries STIC Investment invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
1 more contact available
Round size
- Series A
- $1.1M–$17M
- Series C
- $25M–$72M
- Private Equity
- $52M–$200M
Investment Focus
Industry
- Medical 6 (13%)
- E-Commerce 6 (13%)
- Information Technology 6 (13%)
- Health Care 5 (11%)
- Mobile 3 (7%)
Stage
- Series C 7 (15%)
- Private Equity 7 (15%)
- Series A 6 (13%)
- Series D 6 (13%)
- Series B 5 (11%)
Country
- South Korea 19 (41%)
- India 3 (7%)
- Singapore 3 (7%)
- Vietnam 2 (4%)
- United States 2 (4%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Daniel Lee
Managing Partner, Head of Growth Capital, Growth Capital / Partners Committee
|
Managing Partner, Head of Growth Capital, Growth Capital / Partners Committee | Total investments: 0 | Find email | |
Jong Ha Bae
Operating Partner
|
Operating Partner | Total investments: 0 | Find email | |
Kang Shin-woo
Operating Partner
|
Operating Partner | Total investments: 0 | Find email | |
YEE In Chan
Operating Partner
|
Operating Partner | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
LabGenomics
|
LabGenomics is a healthcare company specialized in molecular diagnostics. | $13M / Debt Financing / Jun 08, 2026 | |
|
LabGenomics
|
LabGenomics is a healthcare company specialized in molecular diagnostics. | $13M / Post-IPO Debt / Jun 08, 2026 | |
Caring
|
Caring is a visiting medical treatment facility that offers medical consultation. | $27.3M / Series C / May 08, 2026 | |
H2
|
H2 is a Korea-based advanced energy storage company specialized in vanadium redox flow battery which is an optimal solution especially for large-scale and long-duration energy storage. H2 has developed cutting-edge EnerFLOW series energy storage using its own vanadium redox flow batteries, which is commercially available at the moment. H2 isexpected to grow fast and big due to H2's unique design and manufacturing capabilities, and a promising market of large-scale energy storage. | $16M / Convertible Note / Jan 21, 2025 | |
H Energy
|
H Energy provides optimal operation of distributed resources and power brokerage services. | $29.8M / Series C / Oct 07, 2024 | |
CHA Healthcare
|
CHA Healthcare is an integrated healthcare provider. It operates general acute care hospitals and IVF Clinics. It provides a full spectrum of healthcare services. It is established through a spin-off from CHA Biotech. CHA Healthcare's main focus is the management of hospital operations. | $109.3M / Convertible Note / Aug 06, 2024 | |
PineTree Therapeutics
|
PineTree Therapeutics engages in the development of disruptive therapies in Oncology and Immuno-oncology. | $17M / Series A / Jul 30, 2024 | |
Zeno Health
|
Generico is the fastest growing specialized pharmacy retail chain of Generic medicines. Started by IIT Bombay alumni, Generico aims at making healthcare affordable for millions of Indians. It provides the biggest portfolio of generic medicines from the reputed pharma companies under one roof and provide up to 80% lesser price. With 6 storescurrently operational in Mumbai, the target is to reach 100 stores in the next one year. | $25M / Series C / Feb 27, 2024 | |
OKESTRO
|
Okestro is an end-to-end cloud full-stack service. The company's solutions are Contrabass, Viola, Trombone, Okestro CMP, Symphony AI, and Clarinet. It offers CMP, AlaaS, AlOps, DevOps, PaaS, and laaS solutions. It provides B2B services. | $99.3M / Series B / Dec 04, 2023 | |
Musicow
|
Musicow allows investors to buy or sell stakes in copyrights to K-Pop songs in a public auction or an online marketplace. | $45.4M / Series D / May 23, 2023 | |
| See all 46 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does STIC Investment invest in?
STIC Investment invests primarily in Medical, E-Commerce and Information Technology startups, most often at Series C and Private Equity stage. Most of the 46 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is STIC Investment's check size?
STIC Investment typically joins rounds of $1.1M–$17M at Series A, $25M–$72M at Series C and $52M–$200M at Private Equity. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds STIC Investment participates in.
How do I contact STIC Investment?
Public channels for STIC Investment include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at STIC Investment?
The team at STIC Investment includes Daniel Lee (Managing Partner, Head of Growth Capital, Growth Capital / Partners Committee), Jong Ha Bae (Operating Partner) and Kang Shin-woo (Operating Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
